Neoantigen Targeted Therapies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062164
  • May 2021
  • Pharmaceuticals
  • 121 Pages
The Neoantigen Targeted Therapies market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Neoantigen Targeted Therapies market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Achilles Therapeutics, Advaxis, Inc., Frame Cancer Therapeutics, Genocea Biosciences, Inc., Gradalis, Inc., Gritstone Oncology, Immunicum AB, Iovance Biotherapeutics, Inc., Medigene, Neon Therapeutics
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Neoantigen Targeted Therapies market along with their effects over the forecast period. Similarly, according to the region Neoantigen Targeted Therapies market research report includes the study of opportunities available in the market situation.

The Neoantigen Targeted Therapies market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Neoantigen Targeted Therapies Market:
The Neoantigen Targeted Therapies market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Achilles Therapeutics, Advaxis, Inc., Frame Cancer Therapeutics, Genocea Biosciences, Inc., Gradalis, Inc., Gritstone Oncology, Immunicum AB, Iovance Biotherapeutics, Inc., Medigene, Neon Therapeutics

Neoantigen Targeted Therapies Market Segmentation Analysis:
By Therapy Type
Combination Therapy and Monotherapy
End User
Hospitals & Clinics
Medical Research Institutions and Other End Users

Global Neoantigen Targeted Therapies Market Segmentation by Regions:
In regional analysis, Neoantigen Targeted Therapies market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Neoantigen Targeted Therapies market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Neoantigen Targeted Therapies Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Neoantigen Targeted Therapies Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Neoantigen Targeted Therapies Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Neoantigen Targeted Therapies Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Neoantigen Targeted Therapies Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Neoantigen Targeted Therapies market, according to the key region.
  • To study the Neoantigen Targeted Therapies market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Neoantigen Targeted Therapies market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Neoantigen Targeted Therapies research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Neoantigen Targeted Therapies market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Neoantigen Targeted Therapies market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Neoantigen Targeted Therapies market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Neoantigen Targeted Therapies market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Neoantigen Targeted Therapies market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Achilles Therapeutics
  • Advaxis, Inc.
  • Frame Cancer Therapeutics
  • Genocea Biosciences, Inc.
  • Gradalis, Inc.
  • Gritstone Oncology
  • Immunicum AB
  • Iovance Biotherapeutics, Inc.
  • Medigene
  • Neon Therapeutics
  • Combination Therapy and Monotherapy
  • End UserEnd Users

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Neoantigen Targeted Therapies Market Snapshot
          2.1.1. Global Neoantigen Targeted Therapies Market By Therapy Type,2019
               2.1.1.1.Combination Therapy and Monotherapy
          2.1.2. Global Neoantigen Targeted Therapies Market By End UserEnd Users,2019
               2.1.2.1.End UserEnd Users
          2.1.3. Global Neoantigen Targeted Therapies Market By End-use,2019
          2.1.4. Global Neoantigen Targeted Therapies Market By Geography,2019

3. Global Neoantigen Targeted Therapies Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Therapy Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Therapy Type, 2020
     4.2. Global Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028

5. Global Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End UserEnd Users, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End UserEnd Users, 2020
     5.2. Global Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028

6. Global Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028

7. Global Neoantigen Targeted Therapies Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Neoantigen Targeted Therapies Market Analysis, 2018 – 2028 
          7.2.1. North America Neoantigen Targeted Therapies Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028
          7.2.3. North America Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.2.4. North America Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Neoantigen Targeted Therapies Market Analysis, 2018 – 2028 
          7.3.1.  Europe Neoantigen Targeted Therapies Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028
          7.3.3. Europe Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.3.4. Europe Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Neoantigen Targeted Therapies Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Neoantigen Targeted Therapies Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028
          7.4.3. Asia Pacific Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.4.4. Asia Pacific Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Neoantigen Targeted Therapies Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Neoantigen Targeted Therapies Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028
          7.5.3. Latin America Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.5.4. Latin America Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Neoantigen Targeted Therapies Market Analysis, 2018 – 2028 
          7.6.1.  MEA Neoantigen Targeted Therapies Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Neoantigen Targeted Therapies Market Size (US$), By Therapy Type, 2018 – 2028
          7.6.3. MEA Neoantigen Targeted Therapies Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.6.4. MEA Neoantigen Targeted Therapies Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Neoantigen Targeted Therapies Providers
        8.4.1 Achilles Therapeutics
                8.4.1.1 Business Description
                8.4.1.2 Achilles Therapeutics Geographic Operations
                8.4.1.3 Achilles Therapeutics Financial Information
                8.4.1.4 Achilles Therapeutics Product Positions/Portfolio
                8.4.1.5 Achilles Therapeutics Key Developments
        8.4.2 Advaxis, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Advaxis, Inc. Geographic Operations
                8.4.2.3 Advaxis, Inc. Financial Information
                8.4.2.4 Advaxis, Inc. Product Positions/Portfolio
                8.4.2.5 Advaxis, Inc. Key Developments
        8.4.3 Frame Cancer Therapeutics
                8.4.3.1 Business Description
                8.4.3.2 Frame Cancer Therapeutics Geographic Operations
                8.4.3.3 Frame Cancer Therapeutics Financial Information
                8.4.3.4 Frame Cancer Therapeutics Product Positions/Portfolio
                8.4.3.5 Frame Cancer Therapeutics Key Developments
        8.4.4 Genocea Biosciences, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Genocea Biosciences, Inc. Geographic Operations
                8.4.4.3 Genocea Biosciences, Inc. Financial Information
                8.4.4.4 Genocea Biosciences, Inc. Product Positions/Portfolio
                8.4.4.5 Genocea Biosciences, Inc. Key Developments
        8.4.5 Gradalis, Inc.
                8.4.5.1 Business Description
                8.4.5.2 Gradalis, Inc. Geographic Operations
                8.4.5.3 Gradalis, Inc. Financial Information
                8.4.5.4 Gradalis, Inc. Product Positions/Portfolio
                8.4.5.5 Gradalis, Inc. Key Developments
        8.4.6 Gritstone Oncology
                8.4.6.1 Business Description
                8.4.6.2 Gritstone Oncology Geographic Operations
                8.4.6.3 Gritstone Oncology Financial Information
                8.4.6.4 Gritstone Oncology Product Positions/Portfolio
                8.4.6.5 Gritstone Oncology Key Developments
        8.4.7 Immunicum AB
                8.4.7.1 Business Description
                8.4.7.2 Immunicum AB Geographic Operations
                8.4.7.3 Immunicum AB Financial Information
                8.4.7.4 Immunicum AB Product Positions/Portfolio
                8.4.7.5 Immunicum AB Key Developments
        8.4.8 Iovance Biotherapeutics, Inc.
                8.4.8.1 Business Description
                8.4.8.2 Iovance Biotherapeutics, Inc. Geographic Operations
                8.4.8.3 Iovance Biotherapeutics, Inc. Financial Information
                8.4.8.4 Iovance Biotherapeutics, Inc. Product Positions/Portfolio
                8.4.8.5 Iovance Biotherapeutics, Inc. Key Developments
        8.4.9 Medigene
                8.4.9.1 Business Description
                8.4.9.2 Medigene Geographic Operations
                8.4.9.3 Medigene Financial Information
                8.4.9.4 Medigene Product Positions/Portfolio
                8.4.9.5 Medigene Key Developments
        8.4.10 Neon Therapeutics
                8.4.10.1 Business Description
                8.4.10.2 Neon Therapeutics Geographic Operations
                8.4.10.3 Neon Therapeutics Financial Information
                8.4.10.4 Neon Therapeutics Product Positions/Portfolio
                8.4.10.5 Neon Therapeutics Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Neoantigen Targeted Therapies Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Neoantigen Targeted Therapies Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Neoantigen Targeted Therapies Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Neoantigen Targeted Therapies Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Neoantigen Targeted Therapies Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Neoantigen Targeted Therapies Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Neoantigen Targeted Therapies Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Neoantigen Targeted Therapies Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Neoantigen Targeted Therapies Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Neoantigen Targeted Therapies Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Neoantigen Targeted Therapies Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Neoantigen Targeted Therapies Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Neoantigen Targeted Therapies Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Neoantigen Targeted Therapies Market Revenue, By Therapy Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Neoantigen Targeted Therapies Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Neoantigen Targeted Therapies Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Neoantigen Targeted Therapies: Market Segmentation 
FIG. 2 Global Neoantigen Targeted Therapies Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Neoantigen Targeted Therapies Market, By Therapy Type, 2019 (US$ Mn) 
FIG. 5 Global Neoantigen Targeted Therapies Market, By End UserEnd Users, 2019 (US$ Mn) 
FIG. 6 Global Neoantigen Targeted Therapies Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Neoantigen Targeted Therapies Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Neoantigen Targeted Therapies Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Neoantigen Targeted Therapies Providers, 2019
FIG. 11 Global Neoantigen Targeted Therapies Market Revenue Contribution, By Therapy Type, 2019 & 2028 (Value %) 
FIG. 12 Global Neoantigen Targeted Therapies Market Revenue Contribution, By End UserEnd Users, 2019 & 2028 (Value %) 
FIG. 13 Global Neoantigen Targeted Therapies Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Neoantigen Targeted Therapies Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Neoantigen Targeted Therapies Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Neoantigen Targeted Therapies Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Neoantigen Targeted Therapies Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Neoantigen Targeted Therapies Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Neoantigen Targeted Therapies market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Neoantigen Targeted Therapies Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Neoantigen Targeted Therapies Market Value, By Segment1, 2018 – 2028
TABLE  North America Neoantigen Targeted Therapies Market Value, By Segment2, 2018 – 2028
TABLE  North America Neoantigen Targeted Therapies Market Value, By Country, 2018 – 2028
TABLE  Europe Neoantigen Targeted Therapies Market Value, By Segment1, 2018 – 2028
TABLE  Europe Neoantigen Targeted Therapies Market Value, By Segment2, 2018 – 2028
TABLE  Europe Neoantigen Targeted Therapies Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Neoantigen Targeted Therapies Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Neoantigen Targeted Therapies Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Neoantigen Targeted Therapies Market Value, By Country, 2018 – 2028
TABLE  Latin America Neoantigen Targeted Therapies Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Neoantigen Targeted Therapies Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Neoantigen Targeted Therapies Market Value, By Country, 2018 – 2028
TABLE  MEA Neoantigen Targeted Therapies Market Value, By Segment1, 2018 – 2028
TABLE  MEA Neoantigen Targeted Therapies Market Value, By Segment2, 2018 – 2028
TABLE  MEA Neoantigen Targeted Therapies Market Value, By Country, 2018 – 2028
TABLE  Achilles Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Advaxis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Frame Cancer Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genocea Biosciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gradalis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gritstone Oncology: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Immunicum AB: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Iovance Biotherapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Medigene: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Neon Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Neoantigen Targeted Therapies Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Neoantigen Targeted Therapies Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Neoantigen Targeted Therapies Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Neoantigen Targeted Therapies Market, By Geography, 2019 (US$ Mn)
FIG.  Global Neoantigen Targeted Therapies Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Neoantigen Targeted Therapies Providers, 2016
FIG.  Global Neoantigen Targeted Therapies Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Neoantigen Targeted Therapies Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Neoantigen Targeted Therapies Market Value, 2018 – 2028, (US$ Mn)